MANSFIELD, Mass.--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, today announced a significant capacity expansion of its Kangaroo™ ePump and Kangaroo™ Joey ...
Study Shows Sequential Compression Sleeves Reduce DVT Events in Immobile Stroke Patients MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, ...
Covidien is ramping up production on its Kangaroo ePump and Kangaroo Joey (pictured).--Courtesy of Covidien Now that Abbott Laboratories ($ABT) is getting out of the ...
Covidien's (COV) Kendall SCD system helped cut the development of deep vein thrombosis (DVT) in immobile stroke patients by 29.9% in an independent study of 2,876 subjects. The system also reduced the ...
Amerinet has announced it has signed an agreement with Covidien for vascular therapy products, according to a news release. The agreement, which is effective through Dec. 31, 2014, offers Amerinet ...
An independent study conducted by the University of Edinburgh has successfully demonstrated the effectiveness of Covidien's Kendall SCD(TM) system with Vascular Refill Detection Technology on immobile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback